PageGroup (LON:PAGE – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from GBX 210 to GBX 355 in a report issued on Wednesday,Digital Look reports. The brokerage currently has a buy rating on the stock.
Separately, Jefferies Financial Group reiterated a “hold” rating and issued a GBX 125 price target on shares of PageGroup in a research report on Thursday, May 21st. Two investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of GBX 260.
View Our Latest Research Report on PAGE
PageGroup Stock Performance
PageGroup (LON:PAGE – Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported GBX 1.20 earnings per share for the quarter. PageGroup had a net margin of 0.79% and a return on equity of 5.95%. Equities analysts predict that PageGroup will post 23.5923567 earnings per share for the current year.
About PageGroup
Michael Page Changes Lives…
That’s our Michael Page Purpose, delivered by c.6,000 people in 34 markets, with a gross profit of over £769.6m in 2025.
As a FTSE 250 company, a lot has changed since we were set up in 1976 and the Group continues to grow and evolve. What hasn’t changed is our commitment to the success of our clients and candidates, and our own people.
Our strategy is geared for the long-term. With world-renowned and fully integrated brands, highly trained and motivated consultants, established professional relationships and access to the best candidates, we use our established database and market-leading approach to data and innovation to pursue our objective of being the leading specialist recruitment consultancy in our chosen markets.
Read More
- Five stocks we like better than PageGroup
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for PageGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PageGroup and related companies with MarketBeat.com's FREE daily email newsletter.
